Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial

Horby PW. et al, (2021)

Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

LANDRAY M. et al, (2021), The Lancet

Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2020)

Development and internal validation of a risk score to detect asymptomatic carotid stenosis

Poorthuis M. et al, (2020), European Journal of Vascular and Endovascular Surgery

Conventional and Genetic Evidence on the Association between Adiposity and CKD.

Zhu P. et al, (2020), J Am Soc Nephrol

Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group None., (2020), Lancet. 2020;396(10259):1345-52.

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.

RECOVERY Collaborative Group None. et al, (2020), N Engl J Med

Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group None., (2020), Lancet

CONVENTIONAL AND GENETIC EVIDENCE ON THE ASSOCIATION BETWEEN ADIPOSITY AND CHRONIC KIDNEY DISEASE

HERRINGTON W. et al, (2020), Journal of the American Society of Nephrology

Blood pressure and kidney disease: chicken or egg (or both)?

Staplin N. et al, (2020), Kidney Int, 98, 547 - 549

In patients with coronary disease and CKD, adding an invasive strategy to MT did not improve outcomes.

Herrington WG. and Staplin N., (2020), Ann Intern Med, 173

In patients with coronary disease and CKD, initial invasive therapy did not improve angina-related health status.

Herrington WG. and Staplin N., (2020), Ann Intern Med, 173

Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank.

Zhu P. et al, (2020), Int J Obes (Lond)

Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

LANDRAY M. et al, (2020), New England Journal of Medicine

Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial.

Horby P. et al, (2020)

Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report

Horby P. et al, (2020)

Accelerometer-measured physical activity and functional behaviours among people on dialysis

Nawab K. et al, (2020), Clinical Kidney Journal

Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.

Lamprea-Montealegre JA. et al, (2019), Clin J Am Soc Nephrol

Kidney disease trials for the 21st century: innovations in design and conduct.

Herrington WG. et al, (2019), Nat Rev Nephrol

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.

Herrington WG. et al, (2018), Clin Kidney J, 11, 749 - 761

Load More

Include forthcoming?